The BA.3.2 "Cicada" Variant: What Doctors Are Seeing This Summer

As SARS-CoV-2 continues to evolve, the BA.3.2 subvariant—nicknamed "Cicada" by some clinicians—has gained attention for its rapid spread this summer. Here's what you need to know about COVID BA.3.2 variant symptoms, how it differs (or doesn't) from earlier Omicron strains, and practical steps to stay safe.

---

What Is BA.3.2 ("Cicada")?

• BA.3.2 is a descendant of the Omicron lineage, identified by genomic surveillance programs in multiple countries.
• Its nickname, "Cicada," reflects how this version has suddenly re-emerged in communities—much like a cicada's periodic appearance.
• While BA.3.2 carries a few additional mutations in the spike protein compared to earlier Omicron subvariants, current data suggest:
  • Transmissibility may be modestly higher than some previous Omicron branches.
  • Severity of illness remains similar to other Omicron strains.

This means most people experience mild to moderate symptoms, although individuals at higher risk (unvaccinated, older adults, immunocompromised) still face the greatest chance of serious illness.

---

How It Spreads

• Airborne droplets and aerosols: The primary route remains inhalation of virus particles when an infected person coughs, sneezes, speaks or breathes.
• Surface contact: Less common but possible if you touch contaminated surfaces and then your face.
• Close contacts: Household members, coworkers, or friends in close indoor settings.

Good ventilation, masking in crowded indoor areas, and staying home when sick continue to be key preventive measures.

---

COVID BA.3.2 Variant Symptoms

Doctors across multiple clinics are noting that BA.3.2 generally produces a symptom pattern very similar to recent Omicron strains. Typical COVID BA.3.2 variant symptoms include:

• Runny or stuffy nose
• Sore throat
• Persistent cough (usually dry)
• Fatigue or low energy
• Headache
• Occasional fever (often low-grade, <100.4°F / 38°C)
• Muscle aches and mild body pains
• Loss of taste or smell (less common than in early pandemic waves)
• Gastrointestinal upset (nausea, diarrhea) in a minority of cases

In most healthy adults and children, these symptoms resolve in 3–7 days with rest and basic self-care. However, everyone's experience can differ, so it's wise to monitor closely.

---

What Doctors Are Observing

Based on clinics and hospital reports this summer:

1. Mild to Moderate Illness in Vaccinated Individuals

   • Vaccinated and boosted patients typically report upper-respiratory symptoms without progression to pneumonia.
   • Over-the-counter pain relievers, hydration, and rest often suffice.

2. Breakthrough Infections Are Common

   • Even with up-to-date boosters, BA.3.2 can infect people.
   • Vaccination continues to protect strongly against hospitalization and death.

3. High-Risk Groups Need Extra Caution

   • Older adults (65+) and those with chronic conditions (diabetes, heart disease, lung disease) can still develop severe disease.
   • Immunocompromised individuals may have prolonged viral shedding.

4. Use of Antivirals and Monoclonal Therapies

   • Paxlovid® (nirmatrelvir/ritonavir) remains effective if started within 5 days of symptom onset.
   • Remdesivir or monoclonal antibodies may be used in certain hospital settings.

5. Hospitalization Rates Remain Low

   • Compared to pre-Omicron waves, fewer people require intensive care.
   • Hospitals are watching for rare complications like multisystem inflammatory syndrome in children (MIS-C) and post-COVID conditions.

---

Testing and Diagnosis

• PCR Tests: Still the gold standard; high sensitivity for BA.3.2.
• Rapid Antigen Tests: Useful for quick screening, especially when symptomatic. A negative test does not fully rule out infection—repeat in 24–48 hours if symptoms persist.
• Telehealth Evaluations: Many clinics offer virtual visits to assess the need for antivirals or further testing.

If you're experiencing any of these symptoms and want a clearer understanding of what might be causing them, you can get answers in minutes with a free AI symptom checker that asks targeted questions about your specific situation.

---

Treatment and Self-Care

For most people with mild to moderate COVID BA.3.2 variant symptoms:

• Rest and Hydration: Drink plenty of fluids; avoid alcohol and caffeine.
• Fever and Pain Control: Acetaminophen or ibuprofen as directed.
• Nasal Relief: Saline sprays or rinses to ease congestion.
• Cough Management: Lozenge, honey (over age 1), or cough suppressant if needed.
• Isolation: Stay home for at least 5 days from symptom onset and mask around others for 5 additional days.

When to Consider Antivirals

Contact your healthcare provider promptly if you:

• Are within 5 days of symptom onset, and
• Are aged 60 or older, or
• Have underlying conditions (e.g., diabetes, heart disease, obesity), or
• Are immunocompromised.

Early antiviral therapy can reduce the risk of progression to serious disease.

---

Prevention Strategies

Even as the world learns to live with COVID-19, these measures remain effective against BA.3.2:

• Vaccination & Boosters: Stay current with recommended COVID-19 shots, including any updated Omicron-specific boosters.
• Masks in High-Risk Settings: N95 or KN95 masks in crowded indoor spaces, around high-risk individuals, or if you have symptoms.
• Good Ventilation: Open windows, use air purifiers, or meet outdoors when possible.
• Hand Hygiene: Wash hands frequently with soap for 20 seconds or use alcohol-based sanitizer.
• Stay Home When Sick: Protect others by isolating at the first sign of illness.

---

Monitoring for Complications

Most BA.3.2 infections are uncomplicated. However, seek immediate medical attention if you experience:

• Trouble breathing or shortness of breath
• Persistent chest pain or pressure
• New confusion or inability to wake up
• Bluish lips or face
• Severe dehydration (little to no urine, dizziness)

These could indicate a life-threatening progression. In any emergency, call your local emergency number right away.

---

Looking Ahead

Scientists continue to track BA.3.2 through genetic sequencing and real-world data collection. Early signals point to:

• No Major Increase in Severity: Hospitalization and death rates remain low in vaccinated populations.
• Potential for Ongoing Evolution: SARS-CoV-2 may continue to change, underscoring the need for regular booster updates.

Staying informed through credible sources such as national health agencies and your personal healthcare provider is the best way to navigate this evolving landscape.

---

When to Talk to Your Doctor

If you have any concerns—whether it's prolonged or worsening symptoms, questions about boosters, or underlying health conditions—reach out to your healthcare professional. Not sure if your symptoms warrant a doctor's visit? Start with a quick symptom assessment to get personalized insights that can help you make an informed decision about seeking care.

Remember: nothing replaces personalized medical advice. Speak to a doctor about anything that could be life threatening or serious. Stay safe, stay informed, and take proactive steps to protect yourself and those around you.